DNA methylation biomarkers of myocardial infarction and cardiovascular disease

Background: The epigenetic landscape underlying cardiovascular disease (CVD) is not completely understood and the clinical value of the identified biomarkers is still limited. We aimed to identify differentially methylated loci associated with acute myocardial infarction (AMI) and assess their valid...

Full description

Bibliographic Details
Authors: Fernández Sanlés, Alba, 1988-; Sayols Baixeras, Sergi, 1988-; Subirana Cachinero, Isaac; Sentí Clapés, Mariano; Pérez-Fernández, Silvia; Castro de Moura, Manuel; Esteller, Manel; Marrugat, Jaume, 1954-; Elosua Llanos, Roberto
Format: Article
Status:Published version
Publication date:2021
Country:España
Institution:Universitat Pompeu Fabra
Repository:Repositorio Digital de la UPF
OAI Identifier:oai:repositori.upf.edu:10230/48409
Online Access:http://hdl.handle.net/10230/48409
http://dx.doi.org/10.1186/s13148-021-01078-6
Access Level:Open access
Keyword:Cardiovascular disease
DNA methylation
Epigenome-wide association study
Myocardial infarction
Predictive biomarkers
_version_ 1878730335426969600
author Fernández Sanlés, Alba, 1988-
author2 Sayols Baixeras, Sergi, 1988-
Subirana Cachinero, Isaac
Sentí Clapés, Mariano
Pérez-Fernández, Silvia
Castro de Moura, Manuel
Esteller, Manel
Marrugat, Jaume, 1954-
Elosua Llanos, Roberto
author2_role author
author
author
author
author
author
author
author
author_browse Castro de Moura, Manuel
Elosua Llanos, Roberto
Esteller, Manel
Fernández Sanlés, Alba, 1988-
Marrugat, Jaume, 1954-
Pérez-Fernández, Silvia
Sayols Baixeras, Sergi, 1988-
Sentí Clapés, Mariano
Subirana Cachinero, Isaac
author_facet Fernández Sanlés, Alba, 1988-
Sayols Baixeras, Sergi, 1988-
Subirana Cachinero, Isaac
Sentí Clapés, Mariano
Pérez-Fernández, Silvia
Castro de Moura, Manuel
Esteller, Manel
Marrugat, Jaume, 1954-
Elosua Llanos, Roberto
author_role author
collection Repositorio Digital de la UPF
description Background: The epigenetic landscape underlying cardiovascular disease (CVD) is not completely understood and the clinical value of the identified biomarkers is still limited. We aimed to identify differentially methylated loci associated with acute myocardial infarction (AMI) and assess their validity as predictive and causal biomarkers. Results: We designed a case-control, two-stage, epigenome-wide association study on AMI (ndiscovery = 391, nvalidation = 204). DNA methylation was assessed using the Infinium MethylationEPIC BeadChip. We performed a fixed-effects meta-analysis of the two samples. 34 CpGs were associated with AMI. Only 12 of them were available in two independent cohort studies (n ~ 1800 and n ~ 2500) with incident coronary and cardiovascular disease (CHD and CVD, respectively). The Infinium HumanMethylation450 BeadChip was used in those two studies. Four of the 12 CpGs were validated in association with incident CHD: AHRR-mapping cg05575921, PTCD2-mapping cg25769469, intergenic cg21566642 and MPO-mapping cg04988978. We then assessed whether methylation risk scores based on those CpGs improved the predictive capacity of the Framingham risk function, but they did not. Finally, we aimed to study the causality of those associations using a Mendelian randomization approach but only one of the CpGs had a genetic influence and therefore the results were not conclusive. Conclusions: We have identified 34 CpGs related to AMI. These loci highlight the relevance of smoking, lipid metabolism, and inflammation in the biological mechanisms related to AMI. Four were additionally associated with incident CHD and CVD but did not provide additional predictive information.
eu_rights_str_mv openAccess
format article
id ES_1a3c384d99d4b8d5b2a00a70b8221fa9
institution Universitat Pompeu Fabra
instname_str Universitat Pompeu Fabra
network_acronym_str ES
network_name_str España
oai_identifier_str oai:repositori.upf.edu:10230/48409
publishDate 2021
publishDateSort 2021
publisher BioMed Central
publisherStr BioMed Central
reponame_str Repositorio Digital de la UPF
spelling DNA methylation biomarkers of myocardial infarction and cardiovascular disease Fernández Sanlés, Alba, 1988- Sayols Baixeras, Sergi, 1988- Subirana Cachinero, Isaac Sentí Clapés, Mariano Pérez-Fernández, Silvia Castro de Moura, Manuel Esteller, Manel Marrugat, Jaume, 1954- Elosua Llanos, Roberto Cardiovascular disease DNA methylation Epigenome-wide association study Myocardial infarction Predictive biomarkers Background: The epigenetic landscape underlying cardiovascular disease (CVD) is not completely understood and the clinical value of the identified biomarkers is still limited. We aimed to identify differentially methylated loci associated with acute myocardial infarction (AMI) and assess their validity as predictive and causal biomarkers. Results: We designed a case-control, two-stage, epigenome-wide association study on AMI (ndiscovery = 391, nvalidation = 204). DNA methylation was assessed using the Infinium MethylationEPIC BeadChip. We performed a fixed-effects meta-analysis of the two samples. 34 CpGs were associated with AMI. Only 12 of them were available in two independent cohort studies (n ~ 1800 and n ~ 2500) with incident coronary and cardiovascular disease (CHD and CVD, respectively). The Infinium HumanMethylation450 BeadChip was used in those two studies. Four of the 12 CpGs were validated in association with incident CHD: AHRR-mapping cg05575921, PTCD2-mapping cg25769469, intergenic cg21566642 and MPO-mapping cg04988978. We then assessed whether methylation risk scores based on those CpGs improved the predictive capacity of the Framingham risk function, but they did not. Finally, we aimed to study the causality of those associations using a Mendelian randomization approach but only one of the CpGs had a genetic influence and therefore the results were not conclusive. Conclusions: We have identified 34 CpGs related to AMI. These loci highlight the relevance of smoking, lipid metabolism, and inflammation in the biological mechanisms related to AMI. Four were additionally associated with incident CHD and CVD but did not provide additional predictive information. BioMed Central http://hdl.handle.net/10230/48409 http://dx.doi.org/10.1186/s13148-021-01078-6
spellingShingle DNA methylation biomarkers of myocardial infarction and cardiovascular disease
Fernández Sanlés, Alba, 1988-
Cardiovascular disease
DNA methylation
Epigenome-wide association study
Myocardial infarction
Predictive biomarkers
status_str publishedVersion
title DNA methylation biomarkers of myocardial infarction and cardiovascular disease
title_full DNA methylation biomarkers of myocardial infarction and cardiovascular disease
title_fullStr DNA methylation biomarkers of myocardial infarction and cardiovascular disease
title_full_unstemmed DNA methylation biomarkers of myocardial infarction and cardiovascular disease
title_short DNA methylation biomarkers of myocardial infarction and cardiovascular disease
title_sort DNA methylation biomarkers of myocardial infarction and cardiovascular disease
topic Cardiovascular disease
DNA methylation
Epigenome-wide association study
Myocardial infarction
Predictive biomarkers
topic_facet Cardiovascular disease
DNA methylation
Epigenome-wide association study
Myocardial infarction
Predictive biomarkers
url http://hdl.handle.net/10230/48409
http://dx.doi.org/10.1186/s13148-021-01078-6